市場調查報告書
商品編碼
1612249
醫療保健人工智慧市場:按技術、服務、應用程式和最終用戶分類 - 全球預測 2025-2030Artificial Intelligence in Healthcare Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End User - Global Forecast 2025-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2023年,人工智慧在醫療保健市場的價值為259.1億美元,預計到2024年將達到324.8億美元,複合年成長率為26.95%,到2030年將達到1377.4億美元。
人工智慧 (AI) 在醫療保健領域的應用範圍廣泛,例如診斷、個人化治療和預測分析。目的是透過利用資料主導的見解和自動化日常業務來改善患者的治療結果。由於對高效醫療保健解決方案的需求不斷成長、患者資料量不斷增加以及降低營運成本的需要,人工智慧是必要的。主要應用包括自動影像分析、追蹤疾病爆發的預測分析、個人化醫療和虛擬助理。最終用途包括希望改善患者照護、簡化工作流程和促進預防性健康措施的醫院、研究機構和保險公司。
主要市場統計 | |
---|---|
基準年[2023] | 259.1億美元 |
預測年份 [2024] | 324.8億美元 |
預測年份 [2030] | 1377.4億美元 |
複合年成長率(%) | 26.95% |
市場成長受到機器學習演算法的進步、數位健康解決方案的日益採用以及政府支持政策的影響。 COVID-19 疫情的爆發進一步加速了遠端醫療和人工智慧的融合,帶來了巨大的成長機會。醫療保健人工智慧新興企業和成熟的科技巨頭正在大力投資研發,為慢性病管理和病患監測的創新解決方案鋪路。然而,資料隱私問題、高昂的初始成本以及缺乏熟練的人工智慧專業人員等挑戰可能會阻礙成長。此外還存在監管障礙和道德考慮。人工智慧系統與現有醫療保健IT基礎設施之間的互通性問題進一步限制了無縫部署。
在創新方面,人工智慧驅動的藥物發現、個人化基因組醫學以及透過穿戴式技術進行即時健康監測等領域有望帶來巨大變化。開發人員應專注於與醫療保健提供者的夥伴關係夥伴關係,共同開發客製化的人工智慧解決方案。投資醫療保健工作者的人工智慧素養和培訓計劃可以縮小技能差距並促進更順利的技術採用。同樣,加強強力的資料管治和隱私保護可以解決相關人員的擔憂並增強對人工智慧採用的信心。總體而言,在技術進步和對以患者為中心的護理日益濃厚的興趣的推動下,人工智慧醫療保健市場仍然充滿活力,這對於願意應對其固有複雜性的相關人員來說是一個絕佳的機會。
市場動態:對醫療保健市場快速發展的人工智慧的關鍵市場洞察
醫療保健領域的人工智慧市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時也能幫助消費行為及其對製造業的影響。
波特五力:駕馭醫療保健人工智慧市場的策略工具
波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。
PESTLE分析:了解醫療保健市場人工智慧的外部影響
外部宏觀環境因素在塑造醫療保健市場人工智慧的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。
市場佔有率分析 了解醫療保健人工智慧市場的競爭格局
對醫療保健市場人工智慧的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。
FPNV 醫療保健市場人工智慧供應商定位矩陣績效評估
FPNV 定位矩陣是評估醫療保健市場人工智慧供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。
策略分析與建議,規劃醫療保健市場人工智慧的成功之路
對於旨在加強其在全球市場的影響力的公司來說,對醫療保健市場中的人工智慧進行策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機並取得長期成功。
1. 市場滲透率:詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。
2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。
3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。
4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。
5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。
1.目前的市場規模和未來的成長預測是多少?
2. 哪些產品、區隔市場和地區提供最佳投資機會?
3.塑造市場的主要技術趨勢和監管影響是什麼?
4.主要廠商的市場佔有率和競爭地位如何?
5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?
The Artificial Intelligence in Healthcare Market was valued at USD 25.91 billion in 2023, expected to reach USD 32.48 billion in 2024, and is projected to grow at a CAGR of 26.95%, to USD 137.74 billion by 2030.
The scope of artificial intelligence (AI) in healthcare encompasses a broad range of applications, including diagnostics, treatment personalizations, and predictive analytics. It aims to enhance patient outcomes by leveraging data-driven insights and automating routine tasks. AI is necessitated by the increasing demand for efficient healthcare solutions, rising patient data volumes, and the need to reduce operational costs. Key applications include automated imaging analysis, predictive analytics for disease outbreak tracking, personalized medicine, and virtual health assistants. End-use spans hospitals, research institutions, and insurance companies aiming to improve patient care, streamline workflows, and foster preventive healthcare measures.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 25.91 billion |
Estimated Year [2024] | USD 32.48 billion |
Forecast Year [2030] | USD 137.74 billion |
CAGR (%) | 26.95% |
Market growth is influenced by advancements in machine learning algorithms, increasing adoption of digital health solutions, and supportive government policies. The integration of AI with telemedicine, further accelerated by the COVID-19 pandemic, presents significant growth opportunities. Healthcare AI startups and established tech giants are investing heavily in R&D, paving the way for innovative solutions addressing chronic disease management and patient monitoring. However, challenges such as data privacy concerns, high initial costs, and a shortage of skilled AI professionals may hinder growth. There are also regulatory hurdles and ethical considerations. Interoperability issues between AI systems and existing healthcare IT infrastructures further limit seamless adoption.
In terms of innovation, areas like AI-driven drug discovery, personalized genomics, and real-time health monitoring via wearable technology promise substantial transformation. Businesses should focus on partnerships and collaborations with healthcare providers to co-develop tailored AI solutions. Investing in AI literacy and training programs for healthcare professionals can bridge skill gaps, ensuring smoother technology adoption. Similarly, reinforcing robust data governance and privacy protection measures can alleviate stakeholders' concerns, fostering trust in AI deployments. Overall, the AI healthcare market remains dynamic, driven by technology advancements and a growing focus on patient-centric care, offering ripe opportunities for stakeholders willing to navigate its inherent complexities.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Healthcare Market
The Artificial Intelligence in Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Healthcare Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Healthcare Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Healthcare Market
A detailed market share analysis in the Artificial Intelligence in Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Healthcare Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Healthcare Market
A strategic analysis of the Artificial Intelligence in Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Artificial Intelligence in Healthcare Market, highlighting leading vendors and their innovative profiles. These include Ada Health GmbH, AiCure, LLC, AllStripes Research Inc., Aspen Technology Inc. by Emerson Electric Co., Atomwise Inc., Augmedix, Inc., Babylon Healthcare Services Ltd., Behold.ai Technologies Limited, Binah.ai, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Clarius Mobile Health Corp., Clinithink Limited, ClosedLoop.ai Inc., Corti ApS, Cyrcardia Asia Limited, Datature.io, Deep Genomics Incorporated, Diabeloop SA, Enlitic, Inc., GE Healthcare, General Vision Inc., Google, LLC by Alphabet, Inc., iCarbonX, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Medasense Biometrics Ltd., Microsoft Corporation, Modernizing Medicine, Inc., Nanox Imaging Ltd., NetBase Quid, Inc., Novo Nordisk A/S, NVIDIA Corporation, Oncora Medical, Oracle Corporation, Owkin, Inc., Oxipit.ai, R1 RCM, Inc., Recursion Pharmaceuticals, Sanofi SA, Sensely, Inc., Shanghai Yitu Technology Co., Ltd., Siemens Healthineers AG, SkinvVision B.V., Subtle Medical, Inc., Tempus Labs, Inc., Turbine Ltd., and Woebot Health.
Market Segmentation & Coverage
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?